<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT944-17545</title>
	</head>
	<body>
		<main>
			<p>941007 FT  07 OCT 94 / UK Company News: Wellcome drug shows promise Wellcome's new shingles drug, which is likely to be launched in several markets over the next year, has had promising results in clinical trials. A new analysis of trials on 1,100 patients shows Valtrex to be 30 per cent faster at reducing pain than Wellcome's Zovirax. It is three times quicker than a placebo. The results were presented yesterday at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy in Orlando, Florida. Wellcome shares rose 18p to 670p. Valtrex was submitted for approval to drug regulatory bodies in Europe and North America in June. Analysts forecast annual sales of up to Dollars 1bn (Pounds 600m).</p>
		</main>
</body></html>
            